Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7276
PUT
ICL Group
ICL
$6.98B
| $773K | ﹤0.01% |
113,700
-85,400
| -43% | -$630K |
|
7277
Clearway Energy Class C
CWEN
$6.8B
| $772K | ﹤0.01% |
+24,636
| New | +$791K |
|
7278
PUT
Invesco WilderHill Clean Energy ETF
PBW
$427M
| $772K | ﹤0.01% |
19,100
+7,300
| +62% | +$307K |
|
7279
PUT
Agios Pharmaceuticals
AGIO
$2.05B
| $772K | ﹤0.01% |
33,600
+2,900
| +9% | +$77K |
|
7280
iShares US Small Cap Value Factor ETF
SVAL
$210M
| $771K | ﹤0.01% |
28,978
+8,673
| +43% | +$250K |
|
|
HAPN
7281
CALL
Happen Inc
HAPN
$2.14B
| $771K | ﹤0.01% |
106,900
-22,800
| -18% | -$203K |
|
7282
CALL
BioXcel Therapeutics
BTAI
$24.5M
| $771K | ﹤0.01% |
2,581
-3,275
| -56% | -$1.4M |
|
7283
PUT
BioCryst Pharmaceuticals
BCRX
$2.48B
| $771K | ﹤0.01% |
92,400
-126,600
| -58% | -$1.22M |
|
7284
Quanterix
QTRX
$127M
| $770K | ﹤0.01% |
68,349
-19,862
| -23% | -$254K |
|
7285
CALL
Thryv Holdings
THRY
$87.5M
| $770K | ﹤0.01% |
33,400
+16,700
| +100% | +$374K |
|
7286
Phibro Animal Health
PAHC
$1.41B
| $770K | ﹤0.01% |
50,270
-109,764
| -69% | -$1.68M |
|
7287
PUT
Amplify Energy
AMPY
$200M
| $769K | ﹤0.01% |
112,000
+5,300
| +5% | +$43.5K |
|
7288
PUT
Rollins
ROL
$17.5B
| $769K | ﹤0.01% |
20,500
-700
| -3% | -$25.3K |
|
7289
PUT
Biomea Fusion
BMEA
$97.9M
| $769K | ﹤0.01% |
24,800
+20,200
| +439% | +$251K |
|
7290
CALL
Bakkt Inc
BKKT
$312M
| $769K | ﹤0.01% |
17,876
-6,848
| -28% | -$266K |
|
7291
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $769K | ﹤0.01% |
23,145
+2,768
| +14% | +$90.1K |
|
7292
PDS Biotechnology
PDSB
$11.6M
| $768K | ﹤0.01% |
124,907
+97,679
| +359% | +$799K |
|
7293
CALL
Invesco DB Base Metals Fund
DBB
$362M
| $768K | ﹤0.01% |
38,000
+33,500
| +744% | +$689K |
|
7294
CALL
Vuzix
VUZI
$260M
| $768K | ﹤0.01% |
185,400
-51,600
| -22% | -$232K |
|
7295
PUT
Schwab US TIPS ETF
SCHP
$16.3B
| $767K | ﹤0.01% |
28,600
+9,000
| +46% | +$237K |
|
7296
CALL
Ethan Allen Interiors
ETD
$569M
| $766K | ﹤0.01% |
27,900
+7,200
| +35% | +$205K |
|
|
CUTR
7297
PUT
DELISTED
Cutera, Inc.
CUTR
| $765K | ﹤0.01% |
32,400
+30,600
| +1,700% | +$978K |
|
7298
Intercorp Financial Services
IFS
$5.97B
| $765K | ﹤0.01% |
33,504
-13,751
| -29% | -$323K |
|
7299
CALL
Direxion Daily Regional Banks Bull 3X ETF
DPST
$384M
| $763K | ﹤0.01% |
9,900
-750
| -7% | -$153K |
|
7300
ProShares Ultra Real Estate
URE
$56.6M
| $763K | ﹤0.01% |
13,267
+7,915
| +148% | +$489K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.